209 related articles for article (PubMed ID: 30450809)
1. Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression.
Qu S; Wu J; Bao Q; Yao B; Duan R; Chen X; Li L; Yuan H; Jin Y; Ma C
J Cell Mol Med; 2019 Feb; 23(2):1116-1127. PubMed ID: 30450809
[TBL] [Abstract][Full Text] [Related]
2. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
3. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
4. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.
Jin T; Zhang Z; Yang XF; Luo JS
Asian Pac J Cancer Prev; 2015; 16(7):2883-7. PubMed ID: 25854377
[TBL] [Abstract][Full Text] [Related]
5. Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4.
Hua T; Wang X; Chi S; Liu Y; Feng D; Zhao Y; Wang H
Oncol Rep; 2018 Aug; 40(2):823-832. PubMed ID: 29901152
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
Liu S; Li L; Zhang Y; Zhang Y; Zhao Y; You X; Lin Z; Zhang X; Ye L
J Biol Chem; 2012 Aug; 287(36):30228-39. PubMed ID: 22740693
[TBL] [Abstract][Full Text] [Related]
7. Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts.
Liu Y; Geng YH; Yang H; Yang H; Zhou YT; Zhang HQ; Tian XX; Fang WG
Cancer Lett; 2018 Aug; 430():1-10. PubMed ID: 29733962
[TBL] [Abstract][Full Text] [Related]
8. Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14.
Wu J; Chen X; Bao Q; Duan R; Jin Y; Shui Y; Yao B; Lu X; Wang Y; Cui H; Li L; Yuan H; Ma C
Cell Physiol Biochem; 2017; 44(3):998-1010. PubMed ID: 29227978
[TBL] [Abstract][Full Text] [Related]
9. Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer.
Yao B; Wang J; Qu S; Liu Y; Jin Y; Lu J; Bao Q; Li L; Yuan H; Ma C
Cell Death Dis; 2019 Jan; 10(1):28. PubMed ID: 30631043
[TBL] [Abstract][Full Text] [Related]
10. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
11. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
12. MALAT1 promotes angiogenesis of breast cancer.
Huang XJ; Xia Y; He GF; Zheng LL; Cai YP; Yin Y; Wu Q
Oncol Rep; 2018 Nov; 40(5):2683-2689. PubMed ID: 30226550
[TBL] [Abstract][Full Text] [Related]
13. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
14. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
15. The Expression Level of S100A4 Protein Affects the Migration Activity of Breast Cancer Cells.
Dukhanina EA; Portseva TN; Kotnova AP; Pankratova EV; Georgieva SG
Dokl Biochem Biophys; 2019 Mar; 485(1):104-106. PubMed ID: 31201625
[TBL] [Abstract][Full Text] [Related]
16. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
Radestock Y; Willing C; Kehlen A; Hoang-Vu C; Hombach-Klonisch S
Mol Cancer Res; 2010 Apr; 8(4):494-506. PubMed ID: 20332215
[TBL] [Abstract][Full Text] [Related]
17. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells.
Santolla MF; Talia M; Maggiolini M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946884
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of NF-κB inducing kinase (NIK) in the mesenchymal lineage using Osterix (Sp7)- or Fibroblast-specific protein 1 (S100a4)-Cre drives spontaneous soft tissue sarcoma.
Davis JL; Thaler R; Cox L; Ricci B; Zannit HM; Wan F; Faccio R; Dudakovic A; van Wijnen AJ; Veis DJ
PLoS One; 2021; 16(7):e0254426. PubMed ID: 34292968
[TBL] [Abstract][Full Text] [Related]
19. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
[TBL] [Abstract][Full Text] [Related]
20. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
